| pubmed-article:16335593 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:16335593 | lifeskim:mentions | umls-concept:C0034716 | lld:lifeskim |
| pubmed-article:16335593 | lifeskim:mentions | umls-concept:C0014257 | lld:lifeskim |
| pubmed-article:16335593 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:16335593 | lifeskim:mentions | umls-concept:C1261322 | lld:lifeskim |
| pubmed-article:16335593 | lifeskim:mentions | umls-concept:C0531264 | lld:lifeskim |
| pubmed-article:16335593 | lifeskim:mentions | umls-concept:C0950966 | lld:lifeskim |
| pubmed-article:16335593 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:16335593 | pubmed:dateCreated | 2005-12-12 | lld:pubmed |
| pubmed-article:16335593 | pubmed:abstractText | The effect of a nitric oxide-donating aspirin derivative, 2-acetoxy-benzoate 3-(nitroxy-methyl)phenyl ester (NCX 4016), and aspirin on the aortic endothelium of diabetic rats was investigated by using scanning and transmission electron microscopy. Control and streptozotocin-treated rats were used. Metabolic control was assessed by measuring blood and urine metabolites, and 24-h urine volume. The ultrastructural study was performed after 7 weeks of diabetes and 6 weeks of therapy. Streptozotocin treatment induced a persistent hyperglycemia which was not influenced by the pharmacological treatments. Values of blood metabolites were in line with the diabetic status. Both scanning and transmission electron microscopy revealed that aortic endothelium was severely damaged in all diabetic rats except for the NCX 4016 treated ones. Our data document the protective effects of NCX 4016 on the vascular endothelium of diabetic rats. Since aspirin had no protective action, NCX 4016 may have exerted its beneficial action by releasing nitric oxide. | lld:pubmed |
| pubmed-article:16335593 | pubmed:language | eng | lld:pubmed |
| pubmed-article:16335593 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16335593 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:16335593 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16335593 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16335593 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16335593 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:16335593 | pubmed:month | Aug | lld:pubmed |
| pubmed-article:16335593 | pubmed:issn | 1122-9497 | lld:pubmed |
| pubmed-article:16335593 | pubmed:author | pubmed-author:AmbrosiniM... | lld:pubmed |
| pubmed-article:16335593 | pubmed:author | pubmed-author:Del SoldatoPP | lld:pubmed |
| pubmed-article:16335593 | pubmed:author | pubmed-author:De AngelisLL | lld:pubmed |
| pubmed-article:16335593 | pubmed:author | pubmed-author:RambottiM GMG | lld:pubmed |
| pubmed-article:16335593 | pubmed:author | pubmed-author:MariucciGG | lld:pubmed |
| pubmed-article:16335593 | pubmed:author | pubmed-author:CovarelliCC | lld:pubmed |
| pubmed-article:16335593 | pubmed:author | pubmed-author:TantucciMM | lld:pubmed |
| pubmed-article:16335593 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:16335593 | pubmed:volume | 37 | lld:pubmed |
| pubmed-article:16335593 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:16335593 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:16335593 | pubmed:pagination | 205-13 | lld:pubmed |
| pubmed-article:16335593 | pubmed:meshHeading | pubmed-meshheading:16335593... | lld:pubmed |
| pubmed-article:16335593 | pubmed:meshHeading | pubmed-meshheading:16335593... | lld:pubmed |
| pubmed-article:16335593 | pubmed:meshHeading | pubmed-meshheading:16335593... | lld:pubmed |
| pubmed-article:16335593 | pubmed:meshHeading | pubmed-meshheading:16335593... | lld:pubmed |
| pubmed-article:16335593 | pubmed:meshHeading | pubmed-meshheading:16335593... | lld:pubmed |
| pubmed-article:16335593 | pubmed:meshHeading | pubmed-meshheading:16335593... | lld:pubmed |
| pubmed-article:16335593 | pubmed:meshHeading | pubmed-meshheading:16335593... | lld:pubmed |
| pubmed-article:16335593 | pubmed:meshHeading | pubmed-meshheading:16335593... | lld:pubmed |
| pubmed-article:16335593 | pubmed:meshHeading | pubmed-meshheading:16335593... | lld:pubmed |
| pubmed-article:16335593 | pubmed:meshHeading | pubmed-meshheading:16335593... | lld:pubmed |
| pubmed-article:16335593 | pubmed:meshHeading | pubmed-meshheading:16335593... | lld:pubmed |
| pubmed-article:16335593 | pubmed:meshHeading | pubmed-meshheading:16335593... | lld:pubmed |
| pubmed-article:16335593 | pubmed:year | 2005 | lld:pubmed |
| pubmed-article:16335593 | pubmed:articleTitle | Ultrastructural investigations on protective effects of NCX 4016 (nitroaspirin) on macrovascular endothelium in diabetic Wistar rats. | lld:pubmed |
| pubmed-article:16335593 | pubmed:affiliation | Department of Experimental Medicine and Biochemical Sciences, University of Perugia, Italy. neurbisp@unipg.it | lld:pubmed |
| pubmed-article:16335593 | pubmed:publicationType | Journal Article | lld:pubmed |
